317 results
8-K
VBIVQ
VBI Vaccines Inc
24 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
to achieve compliance with the Minimum Stockholders’ Equity Requirement, there can be no assurance that the Company will be able to regain compliance
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
and agrees that (A) there can be no assurance that the Manager will be successful in selling the Shares, (B) the Manager will incur no liability or obligation … and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
be no assurance that we will be able to sell any shares under or fully utilize the Sales Agreement with the sales agent.
Risk Factors
Investing in our common … our operations, we must raise additional equity or debt capital in the near term and cannot provide any assurance that we will be successful in doing
8-K
ofvuq npsnnib1pz8e
1 May 24
Other Events
4:15pm
8-K
EX-10.1
b5jbp pgyhzzq0hjsa
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
424B5
k1evaz4xs3byqboatw8
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K
utgdumys4rzswj9ug
6 Feb 24
Entry into a Material Definitive Agreement
4:23pm
8-K
n3zx7oab 72d3pfu
23 Jan 24
Entry into a Material Definitive Agreement
4:15pm
8-K
oijw reaw3o
11 Jan 24
Entry into a Material Definitive Agreement
4:15pm
8-K
lm0m8wf8
26 Dec 23
Entry into a Material Definitive Agreement
4:15pm
8-K
gh4jh63a nf6
12 Dec 23
Entry into a Material Definitive Agreement
4:15pm
8-K
0fl7 9ou8voa
29 Nov 23
Entry into a Material Definitive Agreement
4:15pm